【代表性论文】
1. Sun, W.#,Guo, S.#(共同一作),Li, Y.#, et al.Anoctamin 1 controls bone resorption by coupling Cl− channel activation with RANKL-RANK signaling transduction[J], Nature Communications, 2022, 13(1):2899.
2. Bai, X., Liu, X., Li, S., An, H., Kang, X.,Guo, S.*.Caffeic Acid, an Active Ingredient in Coffee, Combines with DOX for Multitarget Combination Therapy of Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(27):8326-8337.
3.Guo, S.,Bai, X., Shi, S., et al. Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma[J], Biomedicine & pharmacotherapy, 2022, 153:113392.
4. Bai, X., Li, S., Liu, X., An, H., Kang, X.,Guo, S.*. Nuciferine Inhibits TMEM16A in Dietary Adjuvant Therapy for Lung Cancer[J], Journal of Agricultural and Food Chemistry, 2022, 70(12):3687-3696.
5. Chang, L., Chang, R., Shen J., Wang, Y., Song, H., Kang, X., Zhao. Y.,Guo, S.*,Qin, J*. Self-healing pectin/cellulose hydrogel loaded with limonin as TMEM16A inhibitor for lung adenocarcinoma treatment[ J]. International Journal of Biological Macromolecules, 2022, 219: 754-766.
6.Guo, S.,Bai, X., Shi, S., et al. TMEM16A, a homoharringtonine receptor, as a potential endogenic target for lung cancer treatment[J], International Journal of Molecular Sciences, 2021, 22(20):10930.
7.Guo, S.,Bai, X., Liu, Y.F., et al. Inhibition of TMEM16A by natural product silibinin: potential lead compounds for treatment of lung adenocarcinoma[J], Frontiers in Pharmacology, 2021, 12: 643489.
8.Guo, S.,Chen, Y.F., Shi, S., et al. Arctigenin, a novel TMEM16A inhibitor for lung adenocarcinoma therapy[J], Pharmacological Research, 2020, 155: 104721.
9.Guo, S.,Chen, Y.F., Shi, S., et al. The molecular mechanism of ginsenoside analogs activating TMEM16A[J], Biophysical Journal, 2020, 118(1): 262-272.
10.Guo, S.,Qiu, L., Chen, Y.F., et al. TMEM16A-inhibitor loaded pH-responsive nanoparticles: a novel dual-targeting antitumor therapy for lung adenocarcinoma[J], Biochemical Pharmacology, 2020,178:114062.
11.Guo, S.,Wang, H., Pang, C.L., et al. Entering the spotlight: chitosan oligosaccharides as novel activators of CaCCs/TMEM16A[J], Pharmacological Research, 2019, 146: 104323.
12.Guo, S.,Chen, Y.F., Pang, C.L., et al. Matrine is a novel inhibitor of the TMEM16A chloride channel with antilung adenocarcinoma effects[J], Journal of Cellular Physiology, 2019, 234(6): 8698-8708.
13.Guo, S.,Chen, Y.F., Pang, C.L., et al. Ginsenoside Rb1, a novel activator of the TMEM16A chloride channel, augments the contraction of guinea pig ileum[J], Pflugers Archiv : European Journal of Physiology, 2017, 469(5-6): 681-692.
14. Hao, A.Q.#,Guo, S.#(共同一作),Shi, S., et al. Emerging modulators of TMEM16A and their therapeutic potential[J], The Journal of Membrane Biology, 2021, 254(4): 353-365.
15. Huang, Y.Y.#,Guo, S.#(共同一作),Ren, S.X., et al. The natural compound cinnamaldehyde is a novel activator of calcium-activated chloride channel[J], The Journal of Membrane Biology, 2018, 251(5-6): 747-756.3.
